Clinical Trial Update: The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE） [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Efsubaglutide Alfa for obesity/overweight. Recruitment is ongoing, and the study will evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Efsubaglutide Alfa (efsubaglutide alfa)

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Obesity and Overweight | Phase 2 | Status: RECRUITING